One Year After IPO, Asana Shows Outstanding Price & Revenue Strength. World shares mostly higher after US averts shutdown. Japan's next leader sets sights on wage hikes to fuel growth.
View as a Web Page |
Thursday, September 30th |
Good Morning The equities markets made a small rebound on Wednesday but traders and investors shouldn't read too much into the move. The S&P 500 gained about 0.75% at the high of the day while trading in a tight range near the low of the previous session. This is an indication of inherent market weakness and one that could lead to a much deeper decline for the market. If the S&P 500 continues to move lower and falls below the 4,300 level the market could take it down another 200 points or more. The biggest risk this week is the PCE price index on Friday. If the index is hotter than the consensus figure, and there is every reason to think it will be, the onset of tapering at the next FOMC meeting is all but assured. Worse, for the stock market at least, is the fact tighter policy and interest rate hikes will soon follow. |
|
From Our Partners NetPick's Options Specialist, Mike Rykse, reveals his favorite income generating strategy and demonstrates how this strategy can be used on 2 of his favorite markets in just minutes each day and using less than $200 of capital. | See How. | |
|
|
From Our Partners That's the power of using a simple trading strategy that 99% of investors miss. Free book reveals the step-by-step plan. | So get it here now... | |
|
|
From Our Partners The mainstream media will NOT cover this story…
But luckily Teeka Tiwari is revealing all the details of this terrifying new bill that's working its way through Congress.
He'll even give away the name and ticker of his #1 investment for this new trend. | Click here to see it. | |
|
|
|
|
|
The Early Bird Stock Of The Day Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivale... | | |
The Early Bird is a daily email newsletter powered by MarketBeat that covers the top stories that will impact the stock market each day. Read your copy every morning at 7:00 AM Eastern so that you can "catch the worm" when the market opens. | |
Tidak ada komentar:
Posting Komentar